Armstrong, April W., Mark Lebwohl, Richard B. Warren, Howard Sofen, Akimchi Morita, Shinichi Imafuku, Mamitaro Ohtsuki, Lynda Spelman, Thierry Passeron, Kim A. Papp, Matthew J. Colombo, John Vaile, Eleni Vritzali, Kim Hoyt, Carolin Daamen, Subhashis Banerjee, Bruce Strober, Diamant Thaçi, and Andrew Blauvelt. “Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 4 (July 23, 2024): s406. Accessed July 23, 2024. https://jofskin.org/index.php/skin/article/view/2854.